Patients with Hepatic Impairment: No information regarding dose adjustment is offered in the company's labeling. Determined by the literature evaluation, no dose adjustment is likely needed in hepatic impairment.[17] This dose is supplied at the time every three weeks. It’s offered in combination with two chemotherapy drugs: carboplatin and paclitaxel. https://jackj554ufp7.azuria-wiki.com/user